Navigation Links
GlaxoSmithKline Presents Innovative Neuroscience Pipeline
Date:12/13/2007

e portfolio has more than 25 compounds in clinical development and spans a wide variety of central nervous system (CNS) diseases. Many of these compounds have novel mechanisms of action, with the potential to offer significant benefits to patients.

GSK presented new data and development plans for several compounds during the seminar, including:

773812 - A potential major new treatment for schizophrenia:

Schizophrenia is a chronic psychiatric disorder. People with the disease often suffer terrifying symptoms such as delusions, hallucinations, and jumbled or illogical thoughts.

773812 is from the atypical antipsychotic class of medicines, and has the potential to become a major new treatment. Current atypical antipsychotic medicines work by blocking receptors for a variety of neurotransmitters in the brain. However, they have variable receptor binding affinity resulting in different efficacy and safety profiles. GSK has developed '812 as a compound with selectivity towards those receptors that are associated with efficacy, such as the dopamine D2 and serotonin 5HT2 receptors, whilst having minimal activity on receptors believed to be responsible for side-effects, such as dopamine D1, histamine H1, muscarinic M1, alpha and beta adrenergic receptors. This profile has the potential to deliver efficacy similar to the present antipsychotics without troublesome tolerability problems such as sedation, metabolic disturbance, impaired cognition and orthostatic hypotension.

Two studies to assess the efficacy and safety of '812 compared to placebo and olanzapine, a commonly used atypical antipsychotic, in patients with acute schizophrenia have been completed. In these studies, '812 produced a statistically significant improvement in patients compared to placebo (p<0.05), as measured by the Positive and Negative Symptom Scale (PANSS).

Compound '812 was generally well tolerated. In particular, '812 was not associated in either study with m
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. GlaxoSmithKline Responds to JAMA Articles
2. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
3. Congressional Black Caucus Foundation and GlaxoSmithKline Announce Supplier Business Initiative Study Results
4. AUDIO from Medialink and GlaxoSmithKline: A New Nasal Spray for Allergy Relief
5. Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
6. GlaxoSmithKline Aids California Fire Relief Efforts
7. Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program
8. GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
9. Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds
10. Updated GOLD report presents new understandings in diagnosis, treatment and prevention of COPD
11. The Art Of Maternity(TM) at Destination Maternity(R) Presents A Sacred Passage Into Motherhood; the Art of Belly Masking to Belly Casting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2013)... 25, 2013 Imagine running the air conditioner ... loss, hot air and wasted energy! If the home has ... fireplace or clothes dryer, that may be just what is ... often overlooked holes waste energy in the form of higher ... cooling loss in the home. , Drafts occur through the ...
(Date:5/25/2013)... Dr. Leslie Gerstman announced today that ... skin on the neck, on the brow and under the ... , Ultherapy is a non-surgical procedure for the face and ... lift the skin over time. The use of FDA-cleared ultrasound ... then treat the deepest support layers of the skin – ...
(Date:5/25/2013)... Communities of Distinction TV announces May ... largest media market in the United States with almost three ... in Texas and a major convention city. Ft. Worth is ... it is home to many major museums. Both cities offer ... the arts. Residents and locals will be able to watch ...
(Date:5/25/2013)... (HealthDay News) -- Many viruses and parasites that affect ... -- a bacteria-borne illness than can result in liver ... parks, according to a veterinarian. These germs ... the air, said Dr. Susan Nelson, a clinical associate ... of these serious diseases can be fatal, even with ...
(Date:5/25/2013)... 25, 2013 Radius Engineering International ... company in the US and has been building ... over 35 years. M.E. and President, Walton McCarthy, ... NBC Weapon Fundamentals and Shelter Engineering Standards, Sixth ... on shelter engineering. McCarthy is considered the leading ...
Breaking Medicine News(10 mins):Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 2Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 3Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 4Health News:Dr. Leslie Gerstman Is Now Offering the Non-surgical Facelifting Procedure – Ultherapy – in NYC and NJ 2Health News:Communities of Distinction TV Presents May Air Dates for Dallas-Ft. Worth, Texas 2Health News:Hidden Dangers Dog Dog Parks 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 3
... unable to undergo timely surgeries due to long wait ... aimed at evolving methods to cut down// waiting times ... the initial stages. The project has been criticized as ... ,The15-month pilot project is geared to collate ...
... handful of nutrient-rich dried plums each day help keep ... postmenopausal women with osteoporosis or osteoarthritis?// - A ... University College of Human Sciences means to find out. ... the principal investigator and a nationally recognized expert on ...
... is both safe from the cardiovascular// standpoint and effective ... two new studies, published in the January issue of ... for large studies to help clinicians and patients make ... ,"One of the initial surprises is how limited ...
... December 2006 issue of the Journal of Adolescent Health by ... The Miriam Hospital and Brown Medical School, suggests that as ... breakfast and increase their fast food consumption - both behaviors ... ,"Since the transition from adolescence to adulthood appears to be ...
... poultry farm in south western Japan in Kiyotake, around 750 ... ,This has been reported to the agricultural ministry ... out latest by Friday evening. If bird flu is confirmed, ... ,The farm in question has around 12000 ...
... toddlers, parents need to be cautious as it may bring more ... Centre for Disease Control and Prevention in the US has advised ... suffering from cold or cough without consulting their doctor. ... age group of six months in 2005 revealed that they had ...
Cached Medicine News:Health News:Can Prunes Reverse Bone Loss After Menopause? 2Health News:Can Prunes Reverse Bone Loss After Menopause? 3Health News:Benefits Of Testosterone Treatment 2Health News:Skipping Breakfast and Fast Food Consumption - Leads to Weight Gain 2Health News:Skipping Breakfast and Fast Food Consumption - Leads to Weight Gain 3
(Date:5/23/2013)... DIEGO , May 23, 2013  The ... prostate cancer treatment continuum was highlighted prominently at ... American Urological Association (AUA), in San Diego.  According ... high intensity focused ultrasound (HIFU) technology, the need ... disease, and for urologists to consider minimally invasive ...
(Date:5/23/2013)... Mass. , May 23, 2013  Spring Bank ... the treatment of viral infections, today announced that it ... SB 9200, its investigational, once daily, oral therapy for ... in healthy, HCV-infected patients and is designed to assess ... SB 9200 is a first-in-class drug for the treatment ...
(Date:5/23/2013)... AVIV, Israel , May 23, 2013 ... BrainTech Israel 2013 , Israel,s ... place on October 14 th -15 th in ... nd most innovative city in the world by the ... "Start-up Nation." BrainTech Israel 2013 will showcase the ...
Breaking Medicine Technology:Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 2Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 3Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 4Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 5Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 6Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 2Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 3Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 2Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 3
... N.J., May 23, 2011 Today, Roche honored 12 outstanding ... in Chemistry Award for research accomplishments in the field ... two-day Roche Symposium: Excellence in Chemistry ... chemistry plays in pharmaceutical discovery. "These students ...
... Echo Therapeutics, Inc. (OTCBB: ECTE), a company ... wireless, transdermal continuous glucose monitoring (tCGM) system and ... announced that it has received the key components ...  This newly-engineered design is currently undergoing its final ...
Cached Medicine Technology:Roche Symposium Showcases Accomplishments of Next Generation of Chemists 2Echo Therapeutics Announces Symphony™ tCGM System Progress 2Echo Therapeutics Announces Symphony™ tCGM System Progress 3
6.3X Zoom Ratio - Boasting magnifications from 0.8X to 5X, the twin zooming objective optical system developed exclusively by Nikon provides a zoom ratio of 6.3:1. Clickstops at 1X intervals allow ob...
... The CFI Fluor 20x Water Dipping ... and brain research where the objective ... living tissue or brain slice. The ... fluorescent signals with a numberical aperature ...
... The Plan-Neofluar 63x/1.25 Oil Ph3 ... reflected-light reflection contrast. This method ... brightfield microscopy, such as cells ... a Petri dish. Moreover, this ...
... objectives is a series of objectives ... differ from Epiplan objectives by their ... power. Unlike the Epiplan series, the ... objectives. These low-power objectives provide maximum ...
Medicine Products: